Apogee Therapeutics, Inc.
APGE
16 insider filings · Latest: May 6, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jan 14, 2026 | Jan 17 1:00 AM | Michael Thomas HendersonDirector, Chief Executive Officer | Sale | 20,000 | $81.11 | $1.6M | 1,192,987(D) | View → |
| Jan 7, 2026 | Jan 7 9:27 PM | CARL DAMBKOWSKI | Proposed Sale | 35,200 | $78.25 | $2.8M | — | View → |
| Jan 2, 2026 | Jan 2 9:31 PM | JANE HENDERSON | Proposed Sale | 12,000 | $75.48 | $905.8K | — | View → |
| Dec 19, 2025 | Dec 19 9:24 PM | JANE HENDERSON | Proposed Sale | 1,500 | $77.35 | $116.0K | — | View → |
| Dec 4, 2025 | Dec 4 9:43 PM | JANE HENDERSON | Proposed Sale | 1,500 | $74.55 | $111.8K | — | View → |
| Dec 4, 2025 | Dec 4 9:41 PM | CARL DAMBKOWSKI | Proposed Sale | 10,900 | $74.55 | $812.6K | — | View → |
| Nov 25, 2025 | Nov 25 9:28 PM | JANE HENDERSON | Proposed Sale | 1,500 | $67.85 | $101.8K | — | View → |
| Nov 14, 2025 | Nov 14 9:31 PM | JANE HENDERSON | Proposed Sale | 2,000 | $62.97 | $125.9K | — | View → |
| Nov 13, 2025 | Nov 13 3:33 PM | HENDERSON MICHAEL THOMAS | Proposed Sale | 100,000 | $66.98 | $6.7M | — | View → |
| Nov 11, 2025 | Nov 12 12:03 PM | JANE HENDERSON | Proposed Sale | 1,000 | $56.77 | $56.8K | — | View → |
| Nov 5, 2025 | Nov 5 9:17 PM | CARL DAMBKOWSKI | Proposed Sale | 10,785 | $53.90 | $581.3K | — | View → |
| Jul 2, 2025 | Jul 2 8:22 PM | CARL DAMBKOWSKI | Proposed Sale | 22,345 | $44.26 | $989.0K | — | View → |
| Apr 2, 2025 | Apr 2 8:23 PM | CARL DAMBKOWSKI | Proposed Sale | 9,310 | $35.61 | $331.5K | — | View → |
| Mar 5, 2025 | Mar 5 6:46 PM | HENDERSON MICHAEL THOMAS | Proposed Sale | 10,000 | $30.15 | $301.5K | — | View → |
| Feb 5, 2025 | Feb 5 7:02 PM | HENDERSON MICHAEL THOMAS | Proposed Sale | 15,000 | $40.58 | $608.7K | — | View → |
| Jan 8, 2025 | Jan 8 5:23 PM | HENDERSON MICHAEL THOMAS | Proposed Sale | 15,000 | $48.85 | $732.7K | — | View → |
| Dec 11, 2024 | Dec 11 9:59 PM | CARL DAMBKOWSKI | Proposed Sale | 18,160 | $48.38 | $878.6K | — | View → |
| Dec 4, 2024 | Dec 4 4:12 PM | HENDERSON MICHAEL THOMAS | Proposed Sale | 15,000 | $46.58 | $698.7K | — | View → |
| Nov 6, 2024 | Nov 6 4:39 PM | HENDERSON MICHAEL THOMAS | Proposed Sale | 15,000 | $59.23 | $888.4K | — | View → |
| Oct 2, 2024 | Oct 2 8:20 PM | CARL DAMBKOWSKI | Proposed Sale | 16,010 | $57.31 | $917.5K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 6, 2026 | May 9 12:00 AM | Carl DambkowskiChief Medical Officer | Option Exercise | 4,125 | $22.86 | 123,040(D) | View → |
| Apr 16, 2026 | Apr 20 8:05 PM | Michael Thomas HendersonDirector, Chief Executive Officer | Option Exercise | 3,000 | $22.86 | 387,012(D) | View → |
| Apr 1, 2026 | Apr 4 12:00 AM | Carl DambkowskiChief Medical Officer | Option Exercise | 4,125 | $22.86 | 127,165(D) | View → |
| Mar 4, 2026 | Mar 7 1:00 AM | Carl DambkowskiChief Medical Officer | Option Exercise | 4,125 | $22.86 | 131,290(D) | View → |
| Feb 4, 2026 | Feb 5 1:02 AM | Carl DambkowskiChief Medical Officer | Option Exercise | 4,125 | $22.86 | 135,415(D) | View → |